| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 45.018 | 222.604 | 318.644 | 412.664 |
| Total Income - EUR | - | - | - | - | - | - | 45.018 | 222.604 | 320.100 | 412.712 |
| Total Expenses - EUR | - | - | - | - | - | - | 51.939 | 187.880 | 253.300 | 346.812 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.921 | 34.724 | 66.799 | 65.900 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -7.371 | 32.498 | 63.598 | 54.233 |
| Employees | - | - | - | - | - | - | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Epi Expert Medical Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 27.705 | 28.875 | 31.419 | 59.291 |
| Current Assets | - | - | - | - | - | - | 13.588 | 34.000 | 35.720 | 50.543 |
| Inventories | - | - | - | - | - | - | 2.728 | 4.249 | 7.419 | 6.678 |
| Receivables | - | - | - | - | - | - | 647 | 649 | 1.265 | 1.104 |
| Cash | - | - | - | - | - | - | 10.213 | 29.102 | 27.035 | 42.761 |
| Shareholders Funds | - | - | - | - | - | - | -7.169 | 25.307 | 63.800 | 92.788 |
| Social Capital | - | - | - | - | - | - | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | 48.462 | 37.568 | 3.339 | 17.045 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epi Expert Medical Consult S.r.l.